2022
DOI: 10.1089/jop.2021.0084
|View full text |Cite
|
Sign up to set email alerts
|

Comparisons of α2-Adrenergic Agents, Medetomidine and Xylazine, with Pentobarbital for Anesthesia: Important Pitfalls in Diabetic and Nondiabetic Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 56 publications
0
3
0
Order By: Relevance
“…Stability in blood glucose is clinically beneficial in reliably monitoring rats' well-being [31] and differentiating from stress-induced hyperglycaemia or other disease processes. Moreover, stability in blood glucose may be of interest in experimental glucosesensitive measurement and imaging protocols [32].…”
Section: Discussionmentioning
confidence: 99%
“…Stability in blood glucose is clinically beneficial in reliably monitoring rats' well-being [31] and differentiating from stress-induced hyperglycaemia or other disease processes. Moreover, stability in blood glucose may be of interest in experimental glucosesensitive measurement and imaging protocols [32].…”
Section: Discussionmentioning
confidence: 99%
“…For example, Nair and colleagues have compared effects of common sedative drugs, and they found that ketamine/xylazine (which similarly to medetomidine is an alpha-2 adrenergic agonist [ 87 , 88 ]) reduced eye movement as effectively as 1% isoflurane with the muscle relaxant pancuronium [ 89 ]. Besides being a well-established sedative for fMRI, medetomidine has shown to elicit higher electroretinogram responses than ketamine/xylazine [ 90 ]. Due to the long duration of our scanning sessions and the need to have sedated animals with minimal eye movement and strong retinal responses/visual function, we chose medetomidine as the sedative.…”
Section: Discussionmentioning
confidence: 99%
“…Alpha-2 agonists are also known to cause neuroendocrine changes, including blocking insulin release from beta cells and elevating blood glucose levels ( 95 ). These effects were demonstrated in a study by Connell et al ( 96 ), who monitored blood glucose levels of diabetic and non-diabetic rats anesthetized with xylazine, medetomidine or pentobarbital. The authors found that both medetomidine and xylazine, but not pentobarbital, elicited marked hyperglycemia in non-diabetic rats.…”
Section: Methodsmentioning
confidence: 99%